One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

The COVID‐19 pandemic caused by the SARS‐CoV‐2 virus has highlighted the need for
serological assays that can accurately evaluate the neutralizing efficiency of antibodies …

A Esclerose Múltipla é uma doença autoimune crônica e desmielinizante, que envolte
fatores genéticos e ambientais. Acredita-se que dentre esses fatores está a deficiência de …

COVID-19 patients may exhibit neuropsychiatric and neurological symptoms. We found that
anxiety and cognitive impairment are manifested by 28-56% of SARS-CoV-2-infected …

COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals
with uncontrolled glucose levels are more prone to develop the severe form of COVID-…

Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

Background Mutations accrued by SARS-CoV-2 lineage P.1—first detected in Brazil in early
January, 2021—include amino acid changes in the receptor-binding domain of the viral …

… Brunetti; Autoimmune Research Laboratory, Department of Genetics, Microbiology and
Immunology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil; …

Although post-acute cognitive dysfunction and neuroimaging abnormalities have been
reported after hospital discharge in patients recovered from COVID-19, little is known about …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent of a major
global outbreak of respiratory tract disease known as Coronavirus Disease 2019 (COVID-19)…